PSMB2
Proteasome subunit beta type-2
Also known as: HC7-I, PSB2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P49721
- Gene
- PSMB2
- Ensembl
- ENSG00000126067
- Chromosome
- 1
- Canonical length
- 201 aa
- Protein class
- Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Dec 2010]
Canonical amino-acid sequenceUniProt
201 residues, UniProt reviewed canonical sequence.
>P49721|PSMB2
1 MEYLIGIQGP DYVLVASDRV AASNIVQMKD DHDKMFKMSE KILLLCVGEA GDTVQFAEYI
61 QKNVQLYKMR NGYELSPTAA ANFTRRNLAD CLRSRTPYHV NLLLAGYDEH EGPALYYMDY
121 LAALAKAPFA AHGYGAFLTL SILDRYYTPT ISRERAVELL RKCLEELQKR FILNLPTFSV
181 RIIDKNGIHD LDNISFPKQG SLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PSMB2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 28 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 28 nTPM
- liver: 23 nTPM
- bone marrow: 20 nTPM
- thymus: 19 nTPM
- tonsil: 16 nTPM
- spinal cord: 15 nTPM
Single-cell type
- syncytiotrophoblasts: 530 nCPM
- cytotrophoblasts: 484 nCPM
- migrating cytotrophoblasts: 450 nCPM
- extravillous trophoblasts: 397 nCPM
- gastric progenitor cells: 301 nCPM
- esophageal basal cells: 300 nCPM
Immune cell
- non-classical monocyte: 36 nTPM
- intermediate monocyte: 30 nTPM
- plasmacytoid DC: 27 nTPM
- myeloid DC: 26 nTPM
- T-reg: 26 nTPM
- total PBMC: 26 nTPM
Brain region
- pons: 19 nTPM
- white matter: 19 nTPM
- hypothalamus: 18 nTPM
- cerebral cortex: 17 nTPM
- hippocampal formation: 17 nTPM
- medulla oblongata: 17 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.39
- gnomAD pLI
- 0.91
- gnomAD missense Z
- 1.26
- DepMap mean gene effect
- -1.97
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PSMB2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PSMB2 as an antibody target. Whether an autoantibody or antibody against PSMB2 could matter depends on whether native PSMB2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PSMB2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PSMB2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...